Agenda
Filters
AI to Innovate
AI to Optimize
Automated Lab
Connected Lab
Data Strategy
Digital Transformation
Keynote Sessions
Lab Operations
08:45 (CEST)
Introduction & Opening Remarks
08:55 (CEST)
Keynote Sessions
Keynote Sessions
08:55 (CEST)
Moderator’s Introduction and Overview
Michael Shanler, Distinguished VP Analyst, Gartner
09:05 (CEST)
A Golden Age of Technology Advancement in Biopharma: Challenges and Opportunities
Anthony Rowe, VP, Head of Technology - Research Systems, Johnson and Johnson Innovative Medicine
09:20 (CEST)
The R&D Digital Board at Lundbeck – Centralizing Digital Strategy to Optimize use of Novel Technologies
Julie Klint, Director, Head of Molecular Discovery & Enabling Technologies, Lundbeck
09:35 (CEST)
Re-imagining the Research Laboratory Workplace of the Future for Generative AI
Mark Fish, Managing Director and Global Lab Informatics Lead, Accenture
Vincent Sanfiorenzo, Sr. Director of Lab Systems and Sample Management, Merck
09:50 (CEST)
Panel Discussion and Q&A
Michael Shanler, Distinguished VP Analyst, Gartner
Mark Fish, Managing Director and Global Lab Informatics Lead, Accenture
Julie Klint, Director, Head of Molecular Discovery & Enabling Technologies, Lundbeck
Anthony Rowe, VP, Head of Technology - Research Systems, Johnson and Johnson Innovative Medicine
Vincent Sanfiorenzo, Sr. Director of Lab Systems and Sample Management, Merck
Keynote Sessions
10:10 (CEST)
The Application of AI in Drug Development
Daniel Taylor, Head of Digital Science, AstraZeneca
10:25 (CEST)
Pioneering the future of Biopharma R&D – How do we evolve together?
Richard Milne, Vice President & General Manager, Digital Science Solutions, Thermo Fisher Scientific
10:40 (CEST)
Panel Discussion and Q&A
Michael Shanler, Distinguished VP Analyst, Gartner
Richard Milne, Vice President & General Manager, Digital Science Solutions, Thermo Fisher Scientific
Daniel Taylor, Head of Digital Science, AstraZeneca
10:55 (CEST)
Coffee & Networking Break in the Exhibition Area
11:40 (CEST)
Keynote Sessions
Keynote Sessions
11:40 (CEST)
The Servier R&D Data Roadmap – Leveraging Data and Analytics as a Catalyst for Therapeutic Progress
Sophie Ollivier, Chief Data Officer R&D, Servier
11:55 (CEST)
Digital Transformation in Lab Operations: Tools, Integration, and Impact
Priya Vijayakumar, CEO, WattIQ
Doug Martinez, Head of Lab Operations, Gingko Bioworks
12:20 (CEST)
Panel Discussion and Q&A
Priya Vijayakumar, CEO, WattIQ
Doug Martinez, Head of Lab Operations, Gingko Bioworks
Sophie Ollivier, Chief Data Officer R&D, Servier
Keynote Sessions
11:40 (CEST)
Supporting Innovation in the Lab Through the AstraZeneca BioVenture Hub
Pernilla Isberg, Director BioVentureHub, AstraZeneca
11:55 (CEST)
The Roche Innovation Centre – Creating a Hub of Scientific Innovation and Collaboration Where Cutting Edge Research is Done
Sara Munafo, Consultant, Arcondis
12:10 (CEST)
Digital Transformation & Research Tooling
Nicolas Teissie, Product Manager, Software Solutions Life Sciences, Siemens
12:25 (CEST)
Panel Discussion and Q&A
Mark McCord-Amasis, VP, Portfolio Optimization and Design, Pfizer
Pernilla Isberg, Director BioVentureHub, AstraZeneca
Nicolas Teissie, Product Manager, Software Solutions Life Sciences, Siemens
Sara Munafo, Consultant, Arcondis
12:45 (CEST)
Lunch and Networking Break in the Exhibition Area
13:45 (CEST)
Track Sessions
AI to Innovate
13:45 (CEST)
Trust and Transparency in using AI in Drug Discovery
James Malone, CTO, BenevolentAI
14:00 (CEST)
Harnessing an AI Platform for Identification of Novel Natural Small Molecule Therapeutics
Sona Chandra, President of AI, Pangea Bio
14:30 (CEST)
Panel Discussion and Q&A
Thras Karydis, Co-Founder & CTO, DeepCure
James Malone, CTO, BenevolentAI
Sona Chandra, President of AI, Pangea Bio
Automated Lab
13:45 (CEST)
A Real Lab in the Loop in Small Molecule Drug Discovery: Fully Automating the Design-Make-Test-Learn Cycle
Parker Moss, EVP Corporate Development, Exscientia
14:00 (CEST)
Lab Ecosystem Integration is Critical for Digital Transformation
Geoff Gerhardt, Chief Technology Officer, Co-Founder, Scitara
Thomas Schmidt, Marketing Director, Software & Informatics Division, Agilent Technologies
14:30 (CEST)
Panel Discussion and Q&A
Geoff Gerhardt, Chief Technology Officer, Co-Founder, Scitara
Parker Moss, EVP Corporate Development, Exscientia
Thomas Schmidt, Marketing Director, Software & Informatics Division, Agilent Technologies
Digital Transformation
13:45 (CEST)
Digital Transformation at MMIC- Creating Real Time Data Flow from Lab Equipment to Manufacturing
Dave Berry, Director of Digital Business systems - Pharma, CPI (Medicines Manufacturing Innovation Centre)
14:00 (CEST)
Transforming Pharma R&D: Unified Platforms for Data Contextualization and Workflow Orchestration
Teodor Leahu, VP of Strategy & Development, L7 Informatics
14:15 (CEST)
Panel Discussion and Q&A
Dave Berry, Director of Digital Business systems - Pharma, CPI (Medicines Manufacturing Innovation Centre)
Teodor Leahu, VP of Strategy & Development, L7 Informatics
14:45 (CEST)
Track Sessions
AI to Innovate
14:45 (CEST)
Harnessing AI to Achieve Innovation Within Precision Medicine
Jürgen Scheuenpflug, Head of Strategic Innovation, Merck
15:00 (CEST)
Application of LLMs and NLP in the Clinic
Neel Das, LLM Squad Lead, Roche
15:15 (CEST)
Protein Language Model (ProtLM): In-silico approach To Accelerate Vaccine Target Identification
Anjana Dharamshi Singh, Senior Manager Life Science, Cognizant
15:30 (CEST)
Panel Discussion and Q&A
Thras Karydis, Co-Founder & CTO, DeepCure
Anjana Dharamshi Singh, Senior Manager Life Science, Cognizant
Neel Das, LLM Squad Lead, Roche
Jürgen Scheuenpflug, Head of Strategic Innovation, Merck
Digital Transformation
14:45 (CEST)
The Digital Ecosystem at CSL Behring
Dominik Schneider, Senior Manager, R&D Enabling Technology, CSL Behring
15:00 (CEST)
CSL Lab Data Repository – Strategies for Instrument Connectivity and Lab Data Automation
Lukasz Gricman, Senior Manager, R&D Enabling Technologies, CSL Behring
15:15 (CEST)
Problems that AI is solving and creating in drug discovery
Markus Gershater, Chief Scientific Officer and Co-founder, Synthace
15:30 (CEST)
Panel Discussion and Q&A
Markus Gershater, Chief Scientific Officer and Co-founder, Synthace
Lukasz Gricman, Senior Manager, R&D Enabling Technologies, CSL Behring
Dominik Schneider, Senior Manager, R&D Enabling Technology, CSL Behring
15:45 (CEST)
Afternoon Tea and Networking Break in the Exhibition Area
16:30 (CEST)
Track Sessions
Connected Lab
16:30 (CEST)
Data: The Ultimate Asset – Where User Experience meets Data Experience to Redefine Laboratory Data Capture
Penny Smee, Director Product Owner, GSK
16:45 (CEST)
Connected Labs – Digital Transformation of CMC Labs
Nandini Kumar, Research & Labs Practice Leader, Cognizant
Dennis Zolk, Digital R&D Product Owner, Sanofi
Guillaume Lardier, Digital R&D Product Leader, Sanofi
17:15 (CEST)
Panel Discussion and Q&A
Nandini Kumar, Research & Labs Practice Leader, Cognizant
Guillaume Lardier, Digital R&D Product Leader, Sanofi
Dennis Zolk, Digital R&D Product Owner, Sanofi
Penny Smee, Director Product Owner, GSK
Data Strategy
16:30 (CEST)
Making Data GenAI Ready
David Gering, Director - Artificial Intelligence Systems, IDBS
16:45 (CEST)
Unleashing Clinical Insights at the Lakehouse
Vanessa Henning, Clinical Product Architect, Bayer
17:15 (CEST)
Panel Discussion and Q&A
Nick Lynch, Founder, Curlew Research
David Gering, Director - Artificial Intelligence Systems, IDBS
Vanessa Henning, Clinical Product Architect, Bayer
Digital Transformation
16:30 (CEST)
Digital Transformation and Change Management
Thierry Escudier, Portfolio Lead, Pistoia Alliance
16:45 (CEST)
The Lab AI Revolution: Unleashing the Power of AI and Data to Accelerate Research and Discovery
Rob Brown, Global VP of Product, Sapio Sciences
17:00 (CEST)
The Digital Shift: Reshaping the Scientist’s Approach to Work
Kristina Mathis, Investigator, GSK
17:15 (CEST)
Panel Discussion and Q&A
Thierry Escudier, Portfolio Lead, Pistoia Alliance
Rob Brown, Global VP of Product, Sapio Sciences
Kristina Mathis, Investigator, GSK
17:30 (CEST)
Live Labs – Interactive Group Discussions
Michael Shanler, Distinguished VP Analyst, Gartner
Becky Upton, President, Pistoia Alliance

Live Lab sessions are interactive group discussions which tackle the bigger questions of the day in an open forum to brainstorm ideas and discuss the roadblocks to break-through innovation. They take the format of moderated standing discussions. The objective is to share views and experiences to stimulate new ways of thinking about common objectives.

Michael Shanler Distinguished VP Analyst, Gartner

Michael is a VP Distinguished Analysts on Gartner’s Healthcare & Life Science CIO Industry team.  He advises clients on digital business transformation and helps with decisions on technologies that support R&D and Manufacturing IT strategy.  Michael helped coin and champion “digital lab of the future” and has extensive knowledge of laboratory informatics, business process, and IT trends. He advises executives on issues extending across the entire value chain – from early R&D all the way through QC and manufacturing.

Prior to joining Gartner, Mr. Shanler supervised an R&D engineering staff at BD Biosciences where he was focused on new product development (NPD) and technology development and scientific activities. He drove new initiatives and assessed external technologies and acquisition candidates. He also has experience in developing strategic technology and product roadmaps, leading NPD programs,  managing project teams, marshalling innovation efforts, and driving collaborations. While at Pfizer (formerly Genetics Institute), he gained practical experiences in informatics, data automation, and lab instrumentation for drug discovery.  Michael has a BS in Biomedical Engineering from Boston University and has had several patents issued in the scientific space.  He has lived on four different continents and is married to a university professor with whom he has 3 children. Michael has a passion for travel, cooking, race cars and alpine skiing.

Becky Upton President, Pistoia Alliance

Becky was appointed as the Pistoia Alliance’s first female President in June 2022. She is a long-time supporter of pre-competitive collaboration in life sciences and healthcare R&D and the critical role it plays in advancing science and is passionate about diversity in STEM. Becky is responsible for leading the Pistoia Alliance’s strategy and defining its future within areas of increasing importance to the industry, such as data standards, emerging technologies, diversity and inclusion, sustainability, and precision medicine.

Becky first engaged with the Pistoia Alliance on its Lab of the Future project whilst at VWR (now part Avantor) where she worked for over a decade in sales, business development, and scientific services. From here, she joined the scientific instrumentation and analytical services company, Pion, as Managing Director, before moving to the Alliance as a project manager. She later became Chief Portfolio Officer and within this role established the Alliance’s first and thriving Diversity and Inclusion in STEM Leadership program. Becky re-joined the Alliance as President after a return to the commercial world as a Director at Impellam Group where she led the company’s STEM services strategy.

Becky has a PhD in Biochemistry from Imperial College and an MBA from Cranfield University.

 

18:00 (CEST)
Networking Drinks Reception
09:00 (CEST)
Opening Remarks
09:05 (CEST)
Keynote Sessions
Keynote Sessions
09:05 (CEST)
Opening Remarks
Christian Baber, Chief Portfolio Officer, Pistoia Alliance
09:10 (CEST)
From Lab to Impact – Advancing Innovation Through Scientific Collaboration
Karen Koehler, VP, Science Policy & Science Engagement, Bayer
09:25 (CEST)
Incorporating Biotechs into Sanofi and Partnering in AI – a Digital Perspective
Patricia Beau, M&A&D Digital Lead – R&D, Sanofi
09:40 (CEST)
Fatal Attraction & Tech Obsession: Are We Forgetting the Real Value Drivers in Digital Science Transformations?
Paul Denny-Gouldson, Chief Scientist, Zifo Technologies, Ltd
09:55 (CEST)
Panel Discussion and Q&A
Christian Baber, Chief Portfolio Officer, Pistoia Alliance
Paul Denny-Gouldson, Chief Scientist, Zifo Technologies, Ltd
Karen Koehler, VP, Science Policy & Science Engagement, Bayer
Patricia Beau, M&A&D Digital Lead – R&D, Sanofi
Keynote Sessions
10:15 (CEST)
Discovery Without Boundaries: the Lab of the Future at the Francis Crick Institute
James Fleming, CIO, Francis Crick Institute
10:30 (CEST)
Big Pharma Enterprise-Wide Digitally Enabled Business Transformation – How to Connect the Dots
Daniel Vejsig Stephansen, VP, Head of Digital Transformation, Novo Nordisk
10:45 (CEST)
It takes a village: Foster the right ecosystem to optimize your lab operations
Tola Olorunnisola, Senior VP & General Manager – Services, Avantor
11:00 (CEST)
Panel Discussion and Q&A
Keynote Sessions
Christian Baber, Chief Portfolio Officer, Pistoia Alliance
Tola Olorunnisola, Senior VP & General Manager – Services, Avantor
James Fleming, CIO, Francis Crick Institute
Daniel Vejsig Stephansen, VP, Head of Digital Transformation, Novo Nordisk
Christian Baber Chief Portfolio Officer, Pistoia Alliance
Tola Olorunnisola Senior VP & General Manager – Services, Avantor
Tola Olorunnisola serves as the Senior Vice President and General Manager of Advanced Lab Services at Avantor Sciences, a leading provider of innovative products and solutions for the life sciences and advanced technology sectors.In her capacity as GM, Tola’s business unit collaborates closely with scientists and researchers in the lab, offering comprehensive services and digital solutions throughout the scientific process. Her leadership focuses on building a tailored portfolio that delivers operational efficiencies and enhances scientific research to drive groundbreaking discoveries in drug development. Additionally, her unit manages end-to-end supply chain logistics and sample management for various Clinical trials and healthcare applications.With nearly two decades of experience in the Medical Device and Life Science industry, her expertise spans innovation development, strategic and operational execution, enterprise solutions implementation, and business development.
James Fleming CIO, Francis Crick Institute
Daniel Vejsig Stephansen VP, Head of Digital Transformation, Novo Nordisk

As Vice President of Digital Transformation of Novo Nordisk, Daniel oversees the implementation of a Digital Transformation strategy, specifically within drug development. This work includes harnessing AI, automation and data, more efficiently and effectively, as well as re-organization and centralization of processes.

Prior to his role at Novo Nordisk, Daniel worked on managing digital programs in AP at Moeller Maersk, before spending 7 years at LEO Pharma, where he held various leadership positions, ending as Head of Digital Strategy, Partnering and Analytics.

Daniels education has included studies in Computer Science at Aalborg University and Business Administration at Queensland University of Technology as well as Digital Transformation in Healthcare at Harvard Medical School.

11:20 (CEST)
Coffee and Networking Break in the Exhibition Area
12:00 (CEST)
Track Sessions
Automated Lab
12:00 (CEST)
Robotics in Cell Therapy – ACT Smart (Adherent Cell Therapy Using Smart Robotics)
Subash Ramamoorthy, Project Lead Automation & Robotics, Bayer
12:15 (CEST)
The Journey of Implementing an Ultra High-Throughput Screening (uHTS) Automation Facility
Bethan Howells, Senior Automation Scientist, AstraZeneca
12:30 (CEST)
Panel Discussion and Q&A
Bethan Howells, Senior Automation Scientist, AstraZeneca
Subash Ramamoorthy, Project Lead Automation & Robotics, Bayer
Digital Transformation
12:00 (CEST)
Envisioning, Developing, and Executing our Journey Towards the Lab of the Future
Andreas Steinle, Digital Integration lead, Roche
12:15 (CEST)
Building the Lab of the Future From an IT Perspective
Alvaro Minguez Horcajada, Product Manager – Lab Experience, Roche
12:30 (CEST)
Your Digital Transformation Blueprint: Unlocking Next-Gen Lab Informatics
John Egerton, Executive Director, Client Partner, Astrix
12:45 (CEST)
Panel Discussion and Q&A
Alvaro Minguez Horcajada, Product Manager – Lab Experience, Roche
Andreas Steinle, Digital Integration lead, Roche
John Egerton, Executive Director, Client Partner, Astrix
Lab Operations
12:00 (CEST)
The Lab of the Future Supporting Drug Discovery at CRL
Rob Howes, Head of Discovery Sciences UK, Charles River Laboratories
12:15 (CEST)
Optimising Laboratory Operations for Sustainability with Digital Services: Lessons Learned and Best Practices
Charles van Dortmond, EMEA Enterprise Services Engagement Manager, Agilent Technologies
13:30 (CEST)
Panel Discussion and Q&A
Rob Howes, Head of Discovery Sciences UK, Charles River Laboratories
Charles van Dortmond, EMEA Enterprise Services Engagement Manager, Agilent Technologies
13:00 (CEST)
Lunch and Networking Break in the Exhibition Area
14:00 (CEST)
Track Sessions
Automated Lab
14:00 (CEST)
Implementation of a Global CMC System
Amellalih Reza Salgado, Global QA Project Manager, Bayer
14:15 (CEST)
Bridging the Gap: From Strategic Vision to Innovative Execution in CMC Digital
Ricardo Parra-Cruz, Portfolio Lead Industry 4.0, GSK
14:30 (CEST)
Panel Discussion and Q&A
Ricardo Parra-Cruz, Portfolio Lead Industry 4.0, GSK
Amellalih Reza Salgado, Global QA Project Manager, Bayer
Digital Transformation
14:00 (CEST)
Implementing a transformational KM solution to leverage GenAI
Stefano Dal Santo, Head of Knowledge Management, Novartis
14:15 (CEST)
Carrots and Sticks: Towards Implementation of FAIR Data Standards
Sebastian Kube, Senior Data Scientist, Boehringer Ingelheim
14:30 (CEST)
Panel Discussion and Q&A
Sebastian Kube, Senior Data Scientist, Boehringer Ingelheim
Stefano Dal Santo, Head of Knowledge Management, Novartis
Lab Operations
14:00 (CEST)
A Data Driven Approach to Lab Asset Life Cycle Management
Emrah Sueruen, Global Asset Manager, Roche
14:15 (CEST)
Harmonization and Standardisation in Rapid Evolving Business
Tamara McKenna, Director Global LIMS, Clinisys
Nicole Moberg, Chief Executive Officer, Genesis Reference Labs
14:30 (CEST)
Panel Discussion and Q&A
Tamara McKenna, Director Global LIMS, Clinisys
Nicole Moberg, Chief Executive Officer, Genesis Reference Labs
Emrah Sueruen, Global Asset Manager, Roche
14:45 (CEST)
Track Sessions
AI to Optimize
14:45 (CEST)
Leveraging Generative AI to build a Virtual Lab Assistant (VLA)
Martin Curtis-Emerson, Director, Lab and Production Services, Europe, Avantor
Phil De Winne, VP, Digital Collaboration, Data and Emerging Technologies, Avantor
15:00 (CEST)
AI in Pharma Manufacturing: Use Cases & Insights from Lonza
Maria Sedykh, Principal Data Scientist, AI Strategy Lead, Lonza
15:15 (CEST)
Panel Discussion and Q&A
Yann Abraham, Principal Scientist, Janssen
Maria Sedykh, Principal Data Scientist, AI Strategy Lead, Lonza
Martin Curtis-Emerson, Director, Lab and Production Services, Europe, Avantor
Phil De Winne, VP, Digital Collaboration, Data and Emerging Technologies, Avantor
Connected Lab
14:45 (CEST)
How Semantically Enriched Master Data Increases Value of Preclinical Data
Martin Clausen, Product Owner Lab Digitalization, Bayer
15:00 (CEST)
Revolutionizing the scientific experience through enhanced connectivity
Darren Barrington-Light, Sr. Manager, Product Marketing, Thermo Fisher Scientific
15:15 (CEST)
Panel Discussion and Q&A
Darren Barrington-Light, Sr. Manager, Product Marketing, Thermo Fisher Scientific
Martin Clausen, Product Owner Lab Digitalization, Bayer
Data Strategy
14:45 (CEST)
Empowering Scientists Through Data Driven Decision Making in Drug Discovery and Early Development
Nikolaus Stiefl, Portfolio Research Lead, Data & Analytics, pRED, , Roche
15:00 (CEST)
Removing Data Silos within Global Enterprise to Enhance New Product Development and Benefit from Machine Learning
Noel Hollingsworth, CEO & Co-Founder, Uncountable Inc
15:15 (CEST)
Panel Discussion and Q&A
Noel Hollingsworth, CEO & Co-Founder, Uncountable Inc
Nikolaus Stiefl, Portfolio Research Lead, Data & Analytics, pRED, , Roche
15:45 (CEST)
Track Sessions
AI to Innovate
15:45 (CEST)
Towards Self-Driving Development of Cell Therapies
Rickard Sjögren, AI Project Manager, CellVoyant
16:00 (CEST)
AI Toolkit for Precision Oncology: From Drug Development to Treatment
Altuna Akalin, Group Leader, Max Delbruck Center for Molecular Medicine
16:30 (CEST)
Panel Discussion and Q&A
Bryn Williams-Jones, Chief Operating Officer, Connected Discovery
Altuna Akalin, Group Leader, Max Delbruck Center for Molecular Medicine
Rickard Sjögren, AI Project Manager, CellVoyant
Connected Lab
15:45 (CEST)
The Lab of the Future – managing the tech tsunami for scientists
Jini Chavda, Principal IT Business Partner, AstraZeneca
16:00 (CEST)
Beyond the Hype: Unveiling the True Power of Connected Labs
Adam Paton, Principal Consultant, Zifo Technologies, Ltd
16:30 (CEST)
Panel Discussion and Q&A
Adam Paton, Principal Consultant, Zifo Technologies, Ltd
Jini Chavda, Principal IT Business Partner, AstraZeneca
Data Strategy
15:45 (CEST)
The Semantic Lab of the Future
Wolfgang Klute, Director, AstraZeneca
16:00 (CEST)
EMBL-EBI Industry Programme – Disseminating Cutting-Edge Technologies to Industry
Matt Hall, Senior Scientific Officer, EBI-EMBL
16:15 (CEST)
Panel Discussion and Q&A
Wolfgang Klute, Director, AstraZeneca
Matt Hall, Senior Scientific Officer, EBI-EMBL
16:45 (CEST)
Close of Congress